These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
904 related articles for article (PubMed ID: 16958699)
1. Releasing growth factors from activated human platelets after chitosan stimulation: a possible bio-material for platelet-rich plasma preparation. Shen EC; Chou TC; Gau CH; Tu HP; Chen YT; Fu E Clin Oral Implants Res; 2006 Oct; 17(5):572-8. PubMed ID: 16958699 [TBL] [Abstract][Full Text] [Related]
2. Quantitative assessment of the kinetics of growth factors release from platelet gel. Su CY; Kuo YP; Nieh HL; Tseng YH; Burnouf T Transfusion; 2008 Nov; 48(11):2414-20. PubMed ID: 18694465 [TBL] [Abstract][Full Text] [Related]
3. Influence of preparative procedures on assay of platelet function and apparent effects of antiplatelet agents. Madsen NJ; Holmes CE; Serrano FA; Sobel BE; Schneider DJ Am J Cardiol; 2007 Aug; 100(4):722-7. PubMed ID: 17697836 [TBL] [Abstract][Full Text] [Related]
4. Platelet-rich plasma preparation using three devices: implications for platelet activation and platelet growth factor release. Everts PA; Brown Mahoney C; Hoffmann JJ; Schönberger JP; Box HA; van Zundert A; Knape JT Growth Factors; 2006 Sep; 24(3):165-71. PubMed ID: 17079200 [TBL] [Abstract][Full Text] [Related]
5. Stimulus-dependent release of tissue-regenerating factors by equine platelets. Dunkel B; Bolt DM; Smith RK; Cunningham FM Equine Vet J; 2012 May; 44(3):346-54. PubMed ID: 21902713 [TBL] [Abstract][Full Text] [Related]
6. Thrombin receptor occupancy modulates aggregation efficiency and platelet surface expression of vWF and thrombospondin at low thrombin concentrations. Kasirer-Friede A; Legrand C; Frojmovic MM Thromb Haemost; 1999 Jun; 81(6):967-75. PubMed ID: 10404777 [TBL] [Abstract][Full Text] [Related]
7. Preparation of highly concentrated and white cell-poor platelet-rich plasma by plateletpheresis. Zimmermann R; Reske S; Metzler P; Schlegel A; Ringwald J; Eckstein R Vox Sang; 2008 Jul; 95(1):20-5. PubMed ID: 18444946 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the platelet concentrate collection system with the plasma-rich-in-growth-factors kit to produce platelet-rich plasma: a technical report. Weibrich G; Kleis WK; Hitzler WE; Hafner G Int J Oral Maxillofac Implants; 2005; 20(1):118-23. PubMed ID: 15747683 [TBL] [Abstract][Full Text] [Related]
9. Effect of neutrophil adhesion on the size of aggregates formed by agonist-activated platelets. Koda M; Banno Y; Naganawa T Platelets; 2005 Dec; 16(8):482-91. PubMed ID: 16287615 [TBL] [Abstract][Full Text] [Related]
10. Thrombin facilitates primary platelet adhesion onto vascular surfaces in the absence of plasma adhesive proteins: studies under flow conditions. Díaz-Ricart M; Estebanell E; Lozano M; Aznar-Salatti J; White JG; Ordinas A; Escolar G Haematologica; 2000 Mar; 85(3):280-8. PubMed ID: 10702817 [TBL] [Abstract][Full Text] [Related]
11. Influence of ethanol on the release of growth factors in human blood-derived platelet gels. Kuo YP; Lee YL; Tseng YH; Su CH; Burnouf T; Su CY Biologicals; 2010 Jan; 38(1):120-7. PubMed ID: 19720546 [TBL] [Abstract][Full Text] [Related]
12. Effect of different bone substitutes on the concentration of growth factors in platelet-rich plasma. Hee Soon Cho ; Park SY; Kim S; Sang Keun Bae ; Duk Seop Shin ; Ahn MW J Biomater Appl; 2008 May; 22(6):545-57. PubMed ID: 18194993 [TBL] [Abstract][Full Text] [Related]
13. [Preparation of autologous platelet-rich gel for diabetic refractory dermal ulcer and growth factors analysis from it]. Yuan N; Wang C; Wang Y; Yu T; Long Y; Zhang X; Ran X Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Apr; 22(4):468-71. PubMed ID: 18575451 [TBL] [Abstract][Full Text] [Related]
14. Solvent/detergent treatment of platelet concentrates enhances the release of growth factors. Burnouf T; Tseng YH; Kuo YP; Su CY Transfusion; 2008 Jun; 48(6):1090-8. PubMed ID: 18373502 [TBL] [Abstract][Full Text] [Related]
15. The contribution of platelet-derived growth factor, transforming growth factor-beta1, and insulin-like growth factor-I in platelet-rich plasma to the proliferation of osteoblast-like cells. Ogino Y; Ayukawa Y; Kukita T; Koyano K Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Jun; 101(6):724-9. PubMed ID: 16731390 [TBL] [Abstract][Full Text] [Related]
16. Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma. Sundman EA; Cole BJ; Fortier LA Am J Sports Med; 2011 Oct; 39(10):2135-40. PubMed ID: 21846925 [TBL] [Abstract][Full Text] [Related]
17. In vitro release of growth factors from platelet-rich fibrin (PRF): a proposal to optimize the clinical applications of PRF. Su CY; Kuo YP; Tseng YH; Su CH; Burnouf T Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Jul; 108(1):56-61. PubMed ID: 19451002 [TBL] [Abstract][Full Text] [Related]
18. Differential growth factor retention by platelet-rich plasma composites. Tsay RC; Vo J; Burke A; Eisig SB; Lu HH; Landesberg R J Oral Maxillofac Surg; 2005 Apr; 63(4):521-8. PubMed ID: 15789325 [TBL] [Abstract][Full Text] [Related]
19. A novel drilling procedure and subsequent bone autograft preparation: a technical note. Anitua E; Carda C; Andia I Int J Oral Maxillofac Implants; 2007; 22(1):138-45. PubMed ID: 17340908 [TBL] [Abstract][Full Text] [Related]
20. Paracrine up-regulation of monocyte cyclooxygenase-2 by platelets: role of transforming growth factor-beta1. Eligini S; Barbieri SS; Arenaz I; Tremoli E; Colli S Cardiovasc Res; 2007 May; 74(2):270-8. PubMed ID: 17250815 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]